A clinical study of the efficacy on Dibekacin sulfate (DKB) in paranasal sinusitis

Abstract

DKB was used in the treatment of 19 patients with paranasal sinusitis. Eight of these patients were diagnosed with acute sinusitis and 11 with chronic sinusitis. Results were: 1. An improvement of 57.9% as judged by doctors in charge. 2. An improvement of 73.7% by standardized criteria. 3. An improvement of 43.8% in X-ray findings. 4. An eradication of 78.6% including replacement of isolated organisms. 5. No side effects were observed. From the above results it is concluded that DKB is a highly effective antibiotic in the treatment of paranasal sinusitis.